Free Access
Vet. Res.
Volume 34, Number 5, September-October 2003
Mastitis of dairy ruminants
Page(s) 647 - 670
How to cite this article Vet. Res. (2003) 647-670
  1. Andoh A., Fujiyama Y., Bamba T., Hosoda S., Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2, J. Immunol. 151 (1993) 4239-4247 [PubMed].
  2. Barrio B., Rainard P., Poutrel B., Milk complement and the opsonophagocytosis and killing of Staphylococcus aureus mastitis isolates by bovine neutrophils, Microb. Pathog. 34 (2003) 1-9 [PubMed].
  3. Barrow P.A., Hill A.W., The virulence characteristics of strains of Escherichia coli isolated from cases of bovine mastitis in England and Wales, Vet. Microbiol. 20 (1989) 35-48 [CrossRef] [PubMed].
  4. Bjorge L., Jensen T.S., Kristoffersen E.K., Ulstein M., Matre R., Identification of the complement regulatory protein CD59 in human colostrum and milk, Am. J. Reprod. Immunol. 35 (1996) 43-50 [PubMed].
  5. Bohnsack J.F., Chang J.K., Hill H.R., Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species, Infect. Immun. 61 (1993) 1421-1426 [PubMed].
  6. Bohnsack J.F., Widjaja K., Ghazizadeh S., Rubens C.E., Hillyard D.R., Parker C.J., Albertine K.H., Hill H.R., A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections, J. Infect. Dis. 175 (1997) 847-855 [PubMed].
  7. Boulard C., Bencharif F., Étude comparée des érythrocytes de quatre espèces animales dans la détermination de l'activité hémolytique des voies classique et alterne du complément bovin, Comp. Immunol. Microbiol. Infect. Dis. 7 (1984) 27-34 [PubMed].
  8. Brock J.H., Ortega F., Pineiro A., Bactericidal and haemolytic activity of complement in bovine colostrum and serum: effect of proteolytic enzymes and ethylene glycol tetraacetic acid (EGTA), Ann. Immunol. (Paris) 126C (1975) 439-451 [PubMed].
  9. Brown E.J., Gaither T.A., Hammer C.H., Hosea S.W., Frank M.M., The use of conglutinin in a quantitative assay for the presence of cell-bound C3bi and evidence that a single molecule of C3bi is capable of binding conglutinin, J. Immunol. 128 (1982) 860-865 [PubMed].
  10. Carroll E.J., Bactericidal activity of bovine serums against coliform organisms isolated from milk of mastitic udders, udder skin, and environment, Am. J. Vet. Res. 32 (1971) 689-701 [PubMed].
  11. Carroll E.J., In vitro bactericidal reactions of serums and milks obtained from cows inoculated with selected serum-resistant and serum-sensitive coliform bacteria, Am. J. Vet. Res. 35 (1974) 205-211 [PubMed].
  12. Carroll E.J., Jain N.C., Bactericidal activity of normal milk, mastitic milk, and colostrum against Aerobacter aerogenes, Am. J. Vet. Res. 30 (1969) 1123-1132 [PubMed].
  13. Carroll E.J., Crenshaw G.L., Bactericidal activity of bovine neonatal serums for selected coliform bacteria in relation to total protein and immunoglobulin G1 and immunoglobulin M concentrations, Am. J. Vet. Res. 37 (1976) 389-394 [PubMed].
  14. Carroll E.J., Jain N.C., Schalm O.W., Lasmanis J., Experimentally induced coliform mastitis: inoculation of udders with serum-sensitive and serum-resistant organisms, Am. J. Vet. Res. 34 (1973) 1143-1146 [PubMed].
  15. Cheng Q., Stafslien D., Purushothaman S.S., Cleary P., The group B streptococcal C5a peptidase is both a specific protease and an invasin, Infect. Immun. 70 (2002) 2408-2413 [CrossRef] [PubMed].
  16. Colditz I., Watson D., The role of humoral and cellular mediators in enhanced mammary inflammatory reactions to staphylococcal infection in systemically immunized ewes, Microbiol. Immunol. 26 (1982) 1171-1180 [PubMed].
  17. Colditz I.G., Maas P.J., The inflammatory activity of activated complement in ovine and bovine mammary glands, Immunol. Cell Biol. 65 (1987) 433-436 [PubMed].
  18. Colten R., Genetics and synthesis of components of the complement system, in G.D. Ross (Ed.), Immunobiology of the complement system, Academic Press, Inc., Orlando, Florida, 1986, pp. 163-181.
  19. Cooper N.R., Morrison D.C., Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides, J. Immunol. 120 (1978) 1862-1868 [PubMed].
  20. Craven N., Williams M.R., Defences of the bovine mammary gland against infection and prospects for their enhancement, Vet. Immunol. Immunopathol. 10 (1985) 71-127 [PubMed].
  21. Czermak B.J., Sarma V., Bless N.M., Schmal H., Friedl H.P., Ward P.A., In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha, J. Immunol. 162 (1999) 2321-2325 [PubMed].
  22. Damereau B., Biological activities of complement-derived peptides, Rev. Physiol. Biochem. Pharmacol. 108 (1987) 151-206 [PubMed].
  23. De Cueninck B.J., C142 complement activity and conglutinogen in bovine milk, Int. Arch. Allergy Appl. Immunol. 59 (1979) 323-327 [PubMed].
  24. Eckblad W.P., Hendrix K.M., Olson D.P., Total complement hemolytic activity of colostral whey and sera from dairy cows, Cornell. Vet. 71 (1981) 54-58 [PubMed].
  25. Edwards M.S., Nicholson-Weller A., Baker C.J., Kasper D.L., The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus, J. Exp. Med. 151 (1980) 1275-1287 [CrossRef] [PubMed].
  26. Erdei A., Fust G., Gergely J., The role of C3 in the immune response, Immunol. Today 12 (1991) 332-337 [CrossRef] [PubMed].
  27. Fallman M., Andersson R., Andersson T., Signaling properties of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles, J. Immunol. 151 (1993) 330-338 [PubMed].
  28. Fang W., Pyorala S., Mastitis-causing Escherichia coli: serum sensitivity and susceptibility to selected antibacterials in milk, J. Dairy Sci. 79 (1996) 76-82 [PubMed].
  29. Frank M.M., Fries L.F., The role of complement in inflammation and phagocytosis, Immunol. Today 12 (1991) 322-326 [CrossRef] [PubMed].
  30. Fukuoka Y., Medof E.M., C5a receptor-mediated production of IL-8 by the human retinal pigment epithelial cell line, ARPE-19, Curr. Eye Res. 23 (2001) 320-325 [CrossRef] [PubMed].
  31. Gay J.C., Mechanism and regulation of neutrophil priming by platelet-activating factor, J. Cell. Physiol. 156 (1993) 189-197 [PubMed].
  32. Gennaro R., Simonic T., Negri A., Mottola C., Secchi C., Ronchi S., Romeo D., C5a fragment of bovine complement. Purification, bioassays, amino-acid sequence and other structural studies, Eur. J. Biochem. 155 (1986) 77-86 [PubMed].
  33. Goldman A.S., Thorpe L.W., Goldblum R.M., Hanson L.A., Anti-inflammatory properties of human milk, Acta Paediatr. Scand. 75 (1986) 689-695 [PubMed].
  34. Goodman M.G., Chenoweth D.E., Weigle W.O., Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors, J. Exp. Med. 156 (1982) 912-917 [CrossRef] [PubMed].
  35. Grant R.G., Finch J.M., Phagocytosis of Streptococcus uberis by bovine mammary gland macrophages, Res.Vet. Sci. 62 (1997) 74-78.
  36. Gresham H.D., McGarr J.A., Shackelford P.G., Brown E.J., Studies on the molecular mechanisms of human Fc receptor-mediated phagocytosis. Amplification of ingestion is dependent on the generation of reactive oxygen metabolites and is deficient in polymor-phonuclear leukocytes from patients with chronic granulomatous disease, J. Clin. Invest. 82 (1988) 1192-1201 [PubMed].
  37. Guidry A.J., Ost M., Mather I.H., Shainline W.E., Weinland B.T., Sequential response of milk leukocytes, albumin, immunoglobulins, monovalent ions, citrate, and lactose in cows given infusions of Escherichia coli endotoxin into the mammary gland, Am. J. Vet. Res. 44 (1983) 2262-2267 [PubMed].
  38. Hakulinen J., Meri S., Shedding and enrichment of the glycolipid-anchored complement lysis inhibitor protectin (CD59) into milk fat globules, Immunology 85 (1995) 495-501 [PubMed].
  39. Harmon R.J., Schanbacher F.L., Ferguson L.C., Smith K.L., Changes in lactoferrin, immunoglobulin G, bovine serum albumin, and alpha-lactalbumin during acute experimental and natural coliform mastitis in cows, Infect. Immun. 13 (1976) 533-542 [PubMed].
  40. Haviland D.L., McCoy R.L., Whitehead W.T., Akama H., Molmenti E.P., Brown A., Haviland J.C., Parks W.C., Perlmutter D.H., Wetsel R.A., Cellular expression of the C5a anaphylatoxin receptor (C5aR); demonstration of C5aR on nonmyeloid cells of the liver and lung, J. Immunol. (1995) 1861-1869.
  41. Hemming V.G., Hall R.T., Rhodes P.G., Shigeoka A.O., Hill H.R., Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence, J. Clin. Invest. 58 (1976) 1379-1387 [PubMed].
  42. Henson P., A complement to host defence, Nature 383 (1996) 25-26 [CrossRef] [PubMed].
  43. Hill A.W., Shears A.L., Hibbitt K.G., The elimination of serum-resistant Escherichia coli from experimentally infected single mammary glands of healthy cows, Res. Vet. Sci. 25 (1978) 89-93 [PubMed].
  44. Hill A.W., Shears A.L., Hibbitt K.G., The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum, Immunology 34 (1978) 131-136 [PubMed].
  45. Hill A.W., Heneghan D.J., Williams M.R., The opsonic activity of bovine milk whey for the phagocytosis and killing by neutrophils of encapsulated and non-encapsulated Escherichia coli, Vet. Microbiol. 8 (1983) 293-300 [CrossRef] [PubMed].
  46. Hill H.R., Bohnsack J.F., Morris E.Z., Augustine N.H., Parker C.J., Cleary P.P., Wu J.T., Group B streptococci inhibit the chemotactic activity of the fifth component of complement, J. Immunol. 141 (1988) 3551-3556 [PubMed].
  47. Hogan J.S., Todhunter D.A., Smith K.L., Schoenberger P.S., Serum susceptibility of coliforms isolated from bovine intramammary infections, J. Dairy. Sci. 72 (1989) 1893-1899 [PubMed].
  48. Höpken U.E., Lu B., Gerard N.P., Gerard C., The C5a chemoattractant receptor mediates mucosal defence to infection, Nature 383 (1996) 86-89 [CrossRef] [PubMed].
  49. Hostetter M.K., Gordon D.L., Biochemistry of C3 and related thiolester proteins in infection and inflammation, Rev. Infect. Dis. 9 (1987) 97-109 [PubMed].
  50. Howard C.J., Variation in the susceptibility of bovine mycoplasmas to killing by the alternative complement pathway in bovine serum, Immunology 41 (1980) 561-568 [PubMed].
  51. Hsu M.H., Wang M., Browning D.D., Mukaida N., Ye R.D., NF-kappaB activation is required for C5a-induced interleukin-8 gene expression in mononuclear cells, Blood 93 (1999) 3241-3249 [PubMed].
  52. Hugli T.E., Muller-Eberhard H.J., Anaphylatoxins: C3a and C5a, Adv. Immunol. 26 (1978) 1-53 [PubMed].
  53. Jain N.C., Jasper D.E., Carroll E.J., Bactericidal activity for Aerobacter aerogenes of bovine serum and cell-free normal and mastitic milks, Am. J. Vet. Res. 28 (1967) 397-404 [PubMed].
  54. Kai K., Komine K., Komine Y., Kuroishi T., Kozutsumi T., Kobayashi J., Ohta M., Kitamura H., Kumagai K., Lactoferrin stimulates A Staphylococcus aureus killing activity of bovine phagocytes in the mammary gland, Microbiol. Immunol. 46 (2002) 187-194 [PubMed].
  55. Kaipainen T., Pohjanvirta T., Shpigel N.Y., Shwimmer A., Pyorala S., Pelkonen S., Virulence factors of Escherichia coli isolated from bovine clinical mastitis, Vet. Microbiol. 85 (2002) 37-46 [CrossRef] [PubMed].
  56. Kievits F., Kijlstra A., Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin, Immunology 54 (1985) 449-456 [PubMed].
  57. Korhonen H., Syvaoja E.L., Ahola-Luttila H., Sivela S., Kopola S., Husu J., Kosunen T.U., Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori, J. Appl. Bacteriol. 78 (1995) 655-662 [PubMed].
  58. Korhonen H., Marnila P., Gill H.S., Milk immunoglobulins and complement factors, Br. J. Nutr. 84 Suppl 1 (2000) S75-S80.
  59. Lambris J.D., The multifunctional role of C3, the third component of complement, Immunol. Today 9 (1988) 387-393 [CrossRef] [PubMed].
  60. Leijh P.C., van den Barselaar M.T., Daha M.R., van Furth R., Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb, J. Immunol. 129 (1982) 332-337 [PubMed].
  61. Loos M., Wellek B., Thesen R., Opferkuch W., Antibody-independent interaction of the first component of complement with Gram-negative bacteria, Infect. Immun. 22 (1978) 5-9 [PubMed].
  62. Mackie D.P., Pollock D.A., Logan E.F., The opsonic activity of whey and sera from heifers experimentally infected with Streptococcus agalactiae, Br. Vet. J. 141 (1985) 349-354 [PubMed].
  63. Mueller R., Carroll E.J., Panico L., Complement C 3 levels and haemolytic activity in normal and mastitic whey, Zentralbl. Veterinarmed. B. 29 (1982) 99-106 [PubMed].
  64. Mueller R., Carroll E.J., Panico L., Hemolytic complement titers and complement C3 levels in endotoxin- induced mastitis, Am. J. Vet. Res. (1983) 1442-1445.
  65. Muschel L.H., Gustafson L., Larsen L.J., Reexamination of the Neisser-Wechsberg (antibody prozone) phenomenon, Immunology 17 (1969) 525-533 [PubMed].
  66. Naidu A.S., Miedzobrodzki J., Andersson M., Nilsson L.E., Forsgren A., Watts J.L., Bovine lactoferrin binding to six species of coagulase-negative staphylococci isolated from bovine intramammary infections, J. Clin. Microbiol. 28 (1990) 2312-2319 [PubMed].
  67. Naidu A.S., Andersson M., Miedzobrodzki J., Forsgren A., Watts J.L., Bovine lactoferrin receptors in Staphylococcus aureus isolated from bovine mastitis, J. Dairy Sci. 74 (1991) 1218-1226 [PubMed].
  68. O'Gairbhidhe C.P., Jain N.C., Carroll E.J., Schalm O.W., Chemotactic effect of Staphylococcus aureus on neutrophils isolated from the bovine mammary gland, J. Dairy Sci. 53 (1970) 602-604 [PubMed].
  69. Ogundele M., Role and significance of the complement system in mucosal immunity: particular reference to the human breast milk complement, Immunol. Cell Biol. 79 (2001) 1-10 [PubMed].
  70. Ogundele M.O., Inhibitors of complement activity in human breast-milk: a proposed hypothesis of their physiological significance, Mediators Inflamm. 8 (1999) 69-75 [CrossRef] [PubMed].
  71. Ogundele M.O., Anti-complement activities of human breast-milk, Inflamm. Res. 48 (1999) 437-445 [CrossRef] [PubMed].
  72. Paape M.J., Bannerman D.D., Zhao X., Lee J.-W., The bovine neutrophil: structure and function in blood and milk, Vet. Res. 34 (2003) 597-627 [CrossRef] [PubMed] [EDP Sciences].
  73. Pang A.S., Aston W.P., The alternative complement pathway in bovine serum: the isolation of a serum protein with factor B activity, Immunochemistry 15 (1978) 529-534 [CrossRef] [PubMed].
  74. Pangburn M.K., Genetics and synthesis of components of the complement system, in Ross G.D. (Ed.), Immunobiology of the complement system, Academic Press, Inc., Orlando, Florida, 1986, pp. 45-62.
  75. Persson K., Astrom G., Sampling of the bovine teat for studies of defence mechanisms and inflammatory reactions based on a surgical procedure separating the teat and udder cisterns, J. Vet. Med. B 36 (1989) 527-531.
  76. Persson K., Larsson I., Hallen S.C., Effects of certain inflammatory mediators on bovine neutrophil migration in vivo and in vitro, Vet. Immunol. Immunopathol. 37 (1993) 99-112 [PubMed].
  77. Poutrel B., Caffin J.P., A sensitive microassay for the determination of hemolytic complement activity in bovine milk, Vet. Immunol. Immunopathol. 5 (1983) 177-184 [PubMed].
  78. Poutrel B., Rainard P., Hemolytic and bactericidal activities of bovine complement in mammary secretions of cows during the early nonlactating (dry) period, Am. J. Vet. Res. 47 (1986) 1961-1962 [PubMed].
  79. Poutrel B., Caffin J.P., Rainard P., Physiological and pathological factors influencing bovine serum albumin content of milk, J. Dairy. Sci. 66 (1983) 535-541 [PubMed].
  80. Rainard P., Experimental mastitis with Escherichia coli: kinetics of bacteriostatic and bactericidal activities, Ann. Rech. Vet. 14 (1983) 1-11 [PubMed].
  81. Rainard P., Binding of bovine lactoferrin to Streptococcus agalactiae, FEMS Microbiol. Lett. 77 (1992) 235-239 [PubMed].
  82. Rainard P., Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae, Immunology 79 (1993) 648-652 [PubMed].
  83. Rainard P., Complement factor B and the alternative pathway of complement activation in bovine milk, J. Dairy Res. 69 (2002) 1-12 [CrossRef] [PubMed].
  84. Rainard P., Bovine milk fat globules do not inhibit C5a chemotactic activity, Vet. Res. 33 (2002) 413-419 [CrossRef] [PubMed] [EDP Sciences].
  85. Rainard P., Boulard C., Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide, Infect. Immun. 60 (1992) 4801-4808 [PubMed].
  86. Rainard P., Poutrel B., Deposition of complement components on Streptococcus agalactiae in bovine milk in the absence of inflammation, Infect. Immun. 63 (1995) 3422-3427 [PubMed].
  87. Rainard P., Poutrel B., Effect of C5a and tumor necrosis factor-alpha on phagocytosis of Streptococcus agalactiae NT/X and IV/X by bovine neutrophils, Adv. Exp. Med. Biol. 418 (1997) 953-955 [PubMed].
  88. Rainard P., Poutrel B., Generation of complement fragment C5a in milk is variable among cows, J. Dairy Sci. 83 (2000) 945-951 [PubMed].
  89. Rainard P., Poutrel B., Caffin J.P., Assessment of hemolytic and bactericidal complement activities in normal and mastitic bovine milk, J. Dairy Sci. 67 (1984) 614-619 [PubMed].
  90. Rainard P., Lautrou Y., Poutrel B., Ingestion and killing of Streptococcus agalactiae by bovine granulocytes in the presence of natural opsonins, Vet. Microbiol. 18 (1988) 41-50 [CrossRef] [PubMed].
  91. Rainard P., Sarradin P., Paape M.J., Poutrel B., Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk, Vet. Res. 29 (1998) 73-88 [PubMed].
  92. Rainard P., Riollet C., Poutrel B., Paape M.J., Phagocytosis and killing of Staphylococcus aureus by bovine neutrophils after priming by tumor necrosis factor-alpha and the desarginine derivative of C5a, Am. J. Vet. Res. 61 (2000) 951-959 [PubMed].
  93. Reid K.B., The complement system. A major effector mechanism in humoral immunity, The Immunologist 3 (1995) 206-211.
  94. Reiter B., Review of the progress of dairy science: antimicrobial systems in milk, J. Dairy Res. 45 (1978) 131-147 [PubMed].
  95. Reiter B., Oram J.D., Bacterial inhibitors in milk and other biological fluids, Nature (London) 216 (1967) 330 [CrossRef].
  96. Reiter B., Brock J.H., Inhibition of Escherichia coli by bovine colostrum and post-colostral milk. I. Complement-mediated bactericidal activity of antibodies to a serum susceptible strain of E. coli of the serotype O 111, Immunology 28 (1975) 71-82 [PubMed].
  97. Riedemann N.C., Guo R.F., Sarma V.J., Laudes I.J., Huber-Lang M., Warner R.L., Albrecht E.A., Speyer C.L., Ward P.A., Expression and function of the C5a receptor in rat alveolar epithelial cells, J. Immunol. 168 (2002) 1919-1925 [PubMed].
  98. Riollet C., Rainard P., Poutrel B., Differential induction of complement fragment C5a and inflammatory cytokines during intramammary infections with Escherichia coli and Staphylococcus aureus, Clin. Diagn. Lab. Immunol. 7 (2000) 161-167 [CrossRef] [PubMed].
  99. Ross G.D., Opsonization and membrane complement receptors, in: Ross G.D. (Ed.), Immunobiology of the complement system, Academic Press, Orlando, 1986, pp. 87-114.
  100. Sanchez-Carlo V., McDonald J.S., Packer R.A., Virulence factors of Escherichia coli isolated from cows with acute mastitis, Am. J. Vet. Res. 45 (1984) 1775-1777 [PubMed].
  101. Schwaeble W.J., Reid K.B., Does properdin crosslink the cellular and the humoral immune response?, Immunol. Today 20 (1999) 17-21 [CrossRef] [PubMed].
  102. Sethi M.S., Tabel H., Fragment Bb of bovine complement factor B: stimulatory effect on the microbicidal activity of bovine monocytes, Can. J. Vet. Res. 54 (1990) 405-409 [PubMed].
  103. Sethi M.S., Tabel H., Misra V., Activation of bovine monocytes and neutrophils by the Bb fragment of complement factor B: demonstration by the uptake of 3H-deoxyglucose, Can. J. Vet. Res. 54 (1990) 106-112 [PubMed].
  104. Shuster D.E., Kehrli M.E., Jr Rainard P., Paape M., Complement fragment C5a and inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli, Infect. Immun. 65 (1997) 3286-3292 [PubMed].
  105. Smits E., Cifrian E., Guidry A.J., Rainard P., Burvenich C., Paape M.J., Cell culture system for studying bovine neutrophil diapedesis, J. Dairy. Sci. 79 (1996) 1353-1360 [PubMed].
  106. Sordillo L.M., Shafer-Weaver K., DeRosa D., Immunobiology of the mammary gland, J. Dairy Sci. 80 (1997) 1851-1865 [PubMed].
  107. Suankratay C., Zhang X.H., Zhang Y., Lint T.F., Gewurz H., Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway, J. Immunol. 160 (1998) 3006-3013 [PubMed].
  108. Tabel H., Menger M., Aston W.P., Cochran M., Alternative pathway of bovine complement: concentration of factor B, hemolytic activity and heritability, Vet. Immunol. Immunopathol. 5 (1984) 389-398 [PubMed].
  109. Taylor P.W., Bactericidal and bacteriolytic activity of serum against gram-negative bacteria, Microbiol. Rev. 47 (1983) 46-83 [PubMed].
  110. Tomlinson S., Complement defense mechanisms, Curr. Opin. Immunol. 5 (1993) 83-89 [CrossRef] [PubMed].
  111. Triglia R.P., Linscott W.D., Titers of nine complement components, conglutinin and C3b-inactivator in adult and fetal bovine sera, Mol. Immunol. 17 (1980) 741-748 [CrossRef] [PubMed].
  112. Verbrugh H.A., Van Dijk W.C., Peters R., Van Der Tol M.E., Peterson P.K., Verhoef J., Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2, Immunology 36 (1979) 391-397 [PubMed].
  113. Ward G.E., Sebunya T.K., Somatic and capsular factors of coliforms which affect resistance to bovine serum bactericidal activity, Am. J. Vet. Res. 42 (1981) 1937-1940 [PubMed].
  114. Webster R.O., Hong S.R., Johnston R.B. Jr., Henson P.M., Biological effects of the human complement fragments C5a and C5adesArg on neutrophil function, Immunopharmacol. 2 (1980) 201-219.
  115. Wirthmueller U., Dewald B., Thelen M., Schafer M.K., Stover C., Whaley K., North J., Eggleton P., Reid K.B., Schwaeble W.J., Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils, J. Immunol. 158 (1997) 4444-4451 [PubMed].
  116. Wise A.J., Hogan J.S., Cannon V.B., Smith K.L., Phagocytosis and serum susceptibility of Escherichia coli cultured in iron-deplete and iron-replete media, J. Dairy Sci. 85 (2002) 1454-1459 [PubMed].
  117. Yancey K.B., Biological properties of human C5a: selected in vitro and in vivo studies, Clin. Exp. Immunol. 71 (1988) 207-210 [PubMed].